|
시장보고서
상품코드
2055243
망막 박리 시장 : 질환별, 치료법별, 제품 유형별, 진단법별, 연령층별, 최종사용자별, 지역별Retinal Detachment Market, By Disease Type, By Treatment Type, By Product Type, By Diagnostics, By Age Group, By End User, By Geography |
||||||
망막 박리 시장은 2026년 30억 달러로 추정되며, 2033년까지 45억 1,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 6.0%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 30억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.00% | 2033년 시장 규모 예측 : | 45억 1,000만 달러 |
망막 박리는 신경감각망막이 하층의 망막색소상피에서 박리되는 것이 특징인 안과 분야의 중대한 응급 상황으로, 치료를 받지 않으면 영구적인 시력 상실로 이어질 수 있습니다. 이 질환은 천공성, 견인성, 삼출성 박리 등 다양한 기전에 의해 발생하며, 각각에 대해 전문적인 치료가 필요합니다. 전 세계 망막박리 시장은 시력을 위협하는 이 질환을 치료하기 위해 고안된 종합적인 진단 기술, 수술 기구, 의약품 및 치료용 기기를 아우르고 있습니다.
광간섭 단층촬영(OCT), 안저 사진, 초음파 영상 진단과 같은 첨단 진단법은 조기 발견 능력에 혁명을 가져왔습니다. 한편, 기체 망막 고정술, 공막띠술, 유리체 절제술과 같은 혁신적인 수술 기술은 기술의 발전에 따라 계속 진화하고 있습니다. 또한, 저침습 수술법의 도입, 프리미엄 인공수정체, 첨단 유리체망막 수술 기구의 통합으로 시장 경쟁력은 더욱 강화되고 있습니다. 근시, 당뇨병 관련 합병증, 안구 외상, 노화에 따른 퇴행성 변화 등의 위험 요인 유병률 증가가 시장 확대에 크게 기여하고 있습니다. 또한, 의료비 증가, 망막 질환에 대한 인식 제고, 전문적인 안과 의료 서비스 접근성 개선이 이 치료 분야의 눈부신 성장을 이끌고 있으며, 망막 박리 관리는 전 세계 종합 안과 의료 제공 시스템에서 필수적인 요소로서의 입지를 확고히 하고 있습니다.
시장 역학
세계 망막박리 시장은 시장 확대 전망을 종합적으로 높이는 여러 유력한 요인에 힘입어 견조한 성장세를 보이고 있습니다. 주요 시장 성장 요인으로는 전 세계 당뇨병 유병률의 급증 등을 들 수 있습니다. 이는 당뇨병성 망막병증 및 그에 따른 견인성 망막박리의 위험을 현저히 높여, 결과적으로 고도의 치료적 개입에 대한 큰 수요를 낳고 있습니다. 세계적인 고령화 또한 중요한 성장 요인 중 하나입니다. 노화에 따른 퇴행성 변화, 후부 유리체 박리, 근시 유병률 증가가 망막 박리 발생률 상승에 기여하고 있기 때문입니다. 고해상도 광간섭 단층촬영(OCT) 및 광각 안저 촬영을 포함한 영상 진단 기술의 발전으로 조기 발견과 보다 정밀한 치료 계획 수립이 가능해졌으며, 그 결과 환자의 예후가 개선되어 시장 내 도입이 확대되고 있습니다.
또한, 의료비 증가, 전문적인 안과 수술에 대한 보험 적용 범위 확대, 그리고 예방적 안과 관리에 대한 인식 제고가 시장 수요를 크게 끌어올리고 있습니다. 그러나 첨단 유리체망막 수술 장비에 따른 높은 비용이나 의료 종사자에 대한 전문적인 교육 요건 등 몇 가지 제약 요인이 시장 성장의 걸림돌이 되고 있습니다. 이는 개발도상 지역의 접근성 제한으로 이어질 수 있습니다. 또한, 복잡한 상환 제도, 혁신적인 의료기기에 대한 긴 규제 승인 절차, 그리고 환자의 수용을 저해할 수 있는 수술 합병증 역시 시장의 제약 요인으로 작용하고 있습니다.
그럼에도 불구하고, 신흥국에서의 의료 인프라 확충, 최소 침습 수술 기술의 확산, 그리고 안과 연구 개발에 대한 투자 증가를 통해 큰 기회가 창출되고 있습니다. 진단 영상에 인공지능을 접목하고, 신약을 개발하며, 수술 기구를 발전시키는 것은 진화하는 치료 패러다임을 활용하려는 이해관계자들에게 중요한 성장 기회를 제공합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 망막박리 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 망막박리 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 망막 박리 시장 : 질환 유형별, 2021년-2033년
제5장 세계의 망막 박리 시장 : 치료 유형별, 2021년-2033년
제6장 세계의 망막 박리 시장 : 제품 유형별, 2021년-2033년
제7장 세계의 망막 박리 시장 : 진단법별, 2021년-2033년
제8장 세계의 망막 박리 시장 : 연령층별, 2021년-2033년
제9장 세계의 망막 박리 시장 : 최종사용자별, 2021년-2033년
제10장 세계의 망막 박리 시장 : 지역별, 2021년-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고 문헌 및 조사 방법
LSH 26.06.23Retinal Detachment Market is estimated to be valued at USD 3 Bn in 2026 and is expected to reach USD 4.51 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.00% | 2033 Value Projection: | USD 4.51 Bn |
Retinal detachment represents a critical ophthalmological emergency characterized by the separation of the neurosensory retina from the underlying retinal pigment epithelium, potentially leading to permanent vision loss if left untreated. This condition manifests through various mechanisms including rhegmatogenous, tractional, and exudative detachment, each requiring specialized therapeutic interventions. The global retinal detachment market encompasses a comprehensive range of diagnostic technologies, surgical instruments, pharmaceutical agents, and therapeutic devices designed to address this sight-threatening condition.
Advanced diagnostic modalities such as optical coherence tomography, fundus photography, and ultrasound imaging have revolutionized early detection capabilities, while innovative surgical techniques including pneumatic retinopexy, scleral buckling, and vitrectomy procedures continue to evolve with technological advancement. The market landscape is further enhanced by the integration of minimally invasive surgical approaches, premium intraocular lenses, and sophisticated vitreoretinal instrumentation. Rising prevalence of risk factors including myopia, diabetes-related complications, ocular trauma, and age-related degenerative changes significantly contributes to market expansion. Additionally, increasing healthcare expenditure, enhanced awareness regarding retinal disorders, and improved accessibility to specialized ophthalmic care are driving substantial growth in this therapeutic segment, positioning retinal detachment management as a crucial component of comprehensive eye care delivery systems worldwide.
Market Dynamics
The global retinal detachment market demonstrates robust growth trajectories driven by multiple compelling factors that collectively enhance market expansion prospects. Primary market drivers include the escalating prevalence of diabetes mellitus worldwide, which significantly increases the risk of diabetic retinopathy and subsequent tractional retinal detachment, thereby creating substantial demand for advanced therapeutic interventions. The aging global population represents another critical growth driver, as age-related degenerative changes, posterior vitreous detachment, and increased myopia prevalence contribute to heightened retinal detachment incidence rates. Technological advancement in diagnostic imaging, including high-resolution optical coherence tomography and wide-field fundus photography, enables earlier detection and more precise treatment planning, thereby improving patient outcomes and market adoption.
Additionally, increasing healthcare expenditure, enhanced insurance coverage for specialized ophthalmic procedures, and growing awareness regarding preventive eye care significantly boost market demand. However, several restraining factors present challenges to market growth, including the high cost associated with advanced vitreoretinal surgical equipment and specialized training requirements for healthcare professionals, which may limit accessibility in developing regions. Complex reimbursement scenarios, lengthy regulatory approval processes for innovative medical devices, and potential surgical complications that may deter patient acceptance also pose market constraints.
Nevertheless, substantial opportunities emerge through expanding healthcare infrastructure in emerging economies, increasing adoption of minimally invasive surgical techniques, and growing investment in ophthalmic research and development. The integration of artificial intelligence in diagnostic imaging, development of novel pharmacological agents, and advancement in surgical instrumentation present significant growth opportunities for market stakeholders seeking to capitalize on evolving treatment paradigms.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global retinal detachment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Alcon Inc, Carl Zeiss Meditec AG, Bausch + Lomb Incorporated, Topcon Corporation, IRIDEX Corporation, Ellex Medical Lasers Ltd, FCI Ophthalmics, Millennium Surgical Corp, Leica Microsystems GmbH, NIDEK CO., LTD., Escalon Medical Corp, Lumenis Ltd, Second Sight Medical Products Inc, Optos plc, and Johnson & Johnson Vision
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global retinal detachment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global retinal detachment market
Market Segmentation
- Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
- Rhegmatogenous Retinal Detachment
- Tractional Retinal Detachment
- Exudative/Serous/Secondary Retinal Detachment
- Treatment Type Insights (Revenue, USD Bn, 2021 - 2033)
- Vitrectomy
- Scleral Buckling Surgery
- Pneumatic Retinopexy
- Laser treatments (e.g. Photocoagulation)
- Cryopexy
- Other Treatments (adjuncts, combination therapies, newer modalities)
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Surgical Instruments and Equipment
- Consumables and Accessories (e.g. tamponade agents, gases, silicone oil, sutures)
- Diagnostics Insights (Revenue, USD Bn, 2021 - 2033)
- Digital Retinal Camera
- Fundus Photography
- Ophthalmoscopy
- Fluorescent Retinal Angiography
- Other diagnostic modalities
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Children and Adolescents
- Adults
- Seniors
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals/Eye Clinics
- Ophthalmic Centers
- Ambulatory Surgery Centers
- Others (e.g. diagnostic labs, remote tele-ophthalmology services)
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Alcon Inc
- Carl Zeiss Meditec AG
- Bausch + Lomb Incorporated
- Topcon Corporation
- IRIDEX Corporation
- Ellex Medical Lasers Ltd
- FCI Ophthalmics
- Millennium Surgical Corp
- Leica Microsystems GmbH
- NIDEK CO., LTD.
- Escalon Medical Corp
- Lumenis Ltd
- Second Sight Medical Products Inc
- Optos plc
- Johnson & Johnson Vision
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Retinal Detachment Market, By Disease Type
- Global Retinal Detachment Market, By Treatment Type
- Global Retinal Detachment Market, By Product Type
- Global Retinal Detachment Market, By Diagnostics
- Global Retinal Detachment Market, By Age Group
- Global Retinal Detachment Market, By End User
- Global Retinal Detachment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Retinal Detachment Market, By Disease Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Rhegmatogenous Retinal Detachment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Tractional Retinal Detachment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Exudative/Serous/Secondary Retinal Detachment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Retinal Detachment Market, By Treatment Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Vitrectomy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Scleral Buckling Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pneumatic Retinopexy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Laser treatments (e.g. Photocoagulation)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Cryopexy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Treatments (adjuncts, combination therapies, newer modalities)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Retinal Detachment Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Surgical Instruments and Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Consumables and Accessories (e.g. tamponade agents, gases, silicone oil, sutures)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Retinal Detachment Market, By Diagnostics, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Digital Retinal Camera
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fundus Photography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ophthalmoscopy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Fluorescent Retinal Angiography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other diagnostic modalities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Retinal Detachment Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Children and Adolescents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Seniors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Retinal Detachment Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals/Eye Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ophthalmic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (e.g. diagnostic labs, remote tele-ophthalmology services)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Retinal Detachment Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Disease Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Diagnostics, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Alcon Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Carl Zeiss Meditec AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bausch + Lomb Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Topcon Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IRIDEX Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ellex Medical Lasers Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FCI Ophthalmics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Millennium Surgical Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Leica Microsystems GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- NIDEK CO., LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Escalon Medical Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lumenis Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Second Sight Medical Products Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Optos plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Vision
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
